Winsan(Chengdu)Medical Science And Technology Stock Forecast for 2023 - 2025 - 2030
Updated on 05/06/2024
Winsan(Chengdu)Medical Science And Technology Stock Forecast and Price Target
The average target price set lately by experts for Winsan(Chengdu)Medical Science And Technology to reach by the end of the year is ¥0.00, which would imply a potential downside of approximately -,100 percent from the previous closing price if it were to be achieved. This prediction is based on a high estimate of ¥0.00 and a low estimate of ¥0.00. Even if you are not interested in 600767 stock, you should still be aware of its competitors.
N/A
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 900928 Stock Forecast | Shanghai Lingang Holdings | Buy |
16
|
$11.26 | Buy/Sell | $17.00 | 50.98% |
| 600048 Stock Forecast | Poly Developments and Holdings... | Outperform |
18
|
¥8.91 | Buy/Sell | ¥16.97 | 16.72% |
| 000002 Stock Forecast | China Vanke | Outperform |
16
|
¥7.41 | Buy/Sell | ¥14.81 | 18.35% |
| 960 Stock Forecast | Longfor Group Holdings | Buy |
18
|
HK$12.80 | Buy/Sell | HK$16.99 | -2.50% |
| 600606 Stock Forecast | Greenland Holdings Corporation | Hold |
18
|
¥1.84 | Buy/Sell | ¥2.71 | -9.78% |
Winsan(Chengdu)Medical Science And Technology Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Winsan(Chengdu)Medical Science And Technology's Revenue has decreased from ¥48.67M to ¥46.25M – a 4.97% drop. In the coming year, analysts are expecting an increase in Revenue, predicting it will reach ¥49.05M – an increase of 6.04%. Over the next eight years, experts anticipate that Revenue growth for Winsan(Chengdu)Medical Science And Technology will be 6.33%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 601155 Stock Forecast | Seazen Holdings | Hold |
16
|
¥9.85 | Buy/Sell | ¥15.98 | 1.02% |
| 002244 Stock Forecast | Hangzhou Binjiang Real Estate ... | Buy |
15
|
¥6.71 | Buy/Sell | ¥11.14 | 16.24% |
| 600095 Stock Forecast | Xiangcai Co.,Ltd | - |
14
|
¥7.64 | Buy/Sell | ¥7.50 | -100.00% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 600208 Stock Forecast | Xinhu Zhongbao | - |
18
|
¥2.14 | Buy/Sell | ¥3.50 | -100.00% |
| 3900 Stock Forecast | Greentown China Holdings | Buy |
15
|
HK$7.50 | Buy/Sell | HK$10.31 | 19.60% |
| 600246 Stock Forecast | Vantone Neo Development Group | Outperform |
16
|
¥7.75 | Buy/Sell | ¥8.50 | -100.00% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 2007 Stock Forecast | Country Garden Holdings Compan... | Underperform |
16
|
HK$0.49 | Buy/Sell | HK$0.81 | 6.12% |
| 2772 Stock Forecast | Zhongliang Holdings Group Comp... | - |
16
|
HK$0.31 | Buy/Sell | HK$0.00 | -100.00% |
| 600064 Stock Forecast | Nanjing Gaoke Company | - |
16
|
¥5.95 | Buy/Sell | ¥9.54 | -100.00% |
Winsan(Chengdu)Medical Science And Technology EBITDA Forecast for 2023 - 2025 - 2030
Winsan(Chengdu)Medical Science And Technology's EBITDA has decreased by 79.24% In the last two years, from ¥15.80M to ¥3.28M. For next year, the 0 analysts predict EBITDA of ¥16.94M, which would mean an increase of 416.55%. Over the next eight years, the pros' prediction is EBITDAof ¥80.02M, which would mean a eight-year growth forecast of 2339.65%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 2868 Stock Forecast | Beijing Capital Land | - |
16
|
HK$2.78 | Buy/Sell | HK$2.63 | 13.67% |
| 000402 Stock Forecast | Financial Street Holdings | Outperform |
18
|
¥3.47 | Buy/Sell | ¥5.15 | 50.43% |
| 000540 Stock Forecast | Zhongtian Financial Group Comp... | - |
15
|
¥0.40 | Buy/Sell | ¥0.00 | -100.00% |
Winsan(Chengdu)Medical Science And Technology EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Winsan(Chengdu)Medical Science And Technology's EBIT has decreased from ¥8.28M to ¥-1.92M – a 123.19% drop! In the next year, analysts expect EBIT to reach ¥-14.85M – an increase of 673.33%. For the next eight years, the forecast is for EBIT to grow by 8606.21%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 1918 Stock Forecast | Sunac China Holdings | Underperform |
16
|
HK$1.39 | Buy/Sell | HK$1.14 | -10.79% |
| 000048 Stock Forecast | Shenzhen Kingkey Smart Agricul... | Buy |
16
|
¥18.28 | Buy/Sell | ¥0.00 | -100.00% |
| 9968 Stock Forecast | Huijing Holdings Company | - |
14
|
HK$1.96 | Buy/Sell | HK$0.00 | -100.00% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 1030 Stock Forecast | Seazen Group | Hold |
15
|
HK$1.37 | Buy/Sell | HK$1.57 | -19.71% |
| 600158 Stock Forecast | China Sports Industry Group | - |
17
|
¥9.06 | Buy/Sell | ¥8.22 | -100.00% |
| 002146 Stock Forecast | RiseSun Real Estate Developmen... | - |
16
|
¥1.59 | Buy/Sell | ¥0.00 | -100.00% |
Site Navigation
.jpg)